Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cryo nerve block for pain after minimally invasive lung surgery

Official title: A Randomized Controlled Trial Studying the Effect of Additional Intercostal Cryo-analgesia (ICCA) to Standard Postoperative Pain Management in Patients Undergoing Minimally Invasive Lung Surgery

Run by St. Antonius Hospital · NCT06861387 · Data updated 2026-11-12

This study will test whether freezing the intercostal nerves during minimally invasive lung surgery reduces pain and opioid use for adults having VATS or RATS lung resections.

More Minimally Invasive Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorSt. Antonius Hospital
Academic / other
Locations1 site (Nieuwegein, Utrecht)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedJuly 1, 2028
Study endsDecember 12, 2029
Registry record updatedJune 26, 2026
Trial IDNCT06861387 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are electively scheduled for minimally invasive anatomical lung resection (VATS or RATS) and can give informed consent are eligible.

Probably not a fit

Patients on long-term opioids, with liver failure restricting acetaminophen use, connective tissue disease, pregnancy, or other contraindications to ICCA may not receive benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study examines intercostal cryo-analgesia (ICCA), a technique that uses controlled cold to temporarily reduce nerve activity, as an addition to multimodal pain management for patients undergoing minimally invasive anatomic lung resections. Participants undergoing VATS or RATS lobectomy, segmentectomy, or pneumonectomy will receive ICCA plus standard multimodal analgesia and outcomes will be compared with those receiving standard multimodal analgesia alone. Primary outcomes include postoperative pain scores, opioid consumption, and measures of recovery and hospital stay. The trial aims to provide higher-quality comparative data than the small observational studies done so far.

Why it matters

Potential benefit: If successful, ICCA could reduce postoperative pain and opioid requirements and help patients recover faster after minimally invasive lung resection.

How similar studies have gone: Small observational studies and case series have suggested benefit from ICCA in reducing pain and opioid use, but randomized controlled data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients are at least 18 years or older.
2. Patients are electively scheduled to undergo minimally invasive (i.e., VATS or RATS) anatomical lung (i.e., pneumonectomy, (bi)lobectomy, or segmentectomy) resection for benign or malignant disease.
3. Proficient understanding of the consequences of enrolment by the patients.
4. Written informed consent by the patient.

Exclusion Criteria:

1. Patients with reported intolerance or hypersensitivity to the anaesthetic drug used for ICNB.
2. Patients chronically using opioids for reasons not related to the operation (i.e., more than 3 months).
3. Patients with liver failure inhibiting the systematic use of acetaminophen (i.e., paracetamol)
4. Patients with connective tissue disease.
5. Patients with comorbidities or history contra-indicating ICCA.
6. Patients who are pregnant.
7. Participation in other clinical trial(s) that may interfere with the current trial.

Where it's running

  • St. Antonius Ziekenhuis
    Nieuwegein, Utrecht, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.